These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 9553845

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis.
    Pelletier J, Suchet L, Witjas T, Habib M, Guttmann CR, Salamon G, Lyon-Caen O, Chérif AA.
    Arch Neurol; 2001 Jan; 58(1):105-11. PubMed ID: 11176943
    [Abstract] [Full Text] [Related]

  • 3. Anterior corpus callosum atrophy and verbal fluency in multiple sclerosis.
    Pozzilli C, Bastianello S, Padovani A, Passafiume D, Millefiorini E, Bozzao L, Fieschi C.
    Cortex; 1991 Sep; 27(3):441-5. PubMed ID: 1743039
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Functional and magnetic resonance imaging correlates of callosal involvement in multiple sclerosis.
    Pelletier J, Habib M, Lyon-Caen O, Salamon G, Poncet M, Khalil R.
    Arch Neurol; 1993 Oct; 50(10):1077-82. PubMed ID: 8215967
    [Abstract] [Full Text] [Related]

  • 8. Use of combined conventional and quantitative MRI to quantify pathology related to cognitive impairment in multiple sclerosis.
    Lin X, Tench CR, Morgan PS, Constantinescu CS.
    J Neurol Neurosurg Psychiatry; 2008 Apr; 79(4):437-41. PubMed ID: 17673493
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Multimodal assessment of normal-appearing corpus callosum is a useful marker of disability in relapsing-remitting multiple sclerosis: an MRI cluster analysis study.
    Barone S, Caligiuri ME, Valentino P, Cherubini A, Chiriaco C, Granata A, Filippelli E, Tallarico T, Nisticò R, Quattrone A.
    J Neurol; 2018 Oct; 265(10):2243-2250. PubMed ID: 30051273
    [Abstract] [Full Text] [Related]

  • 17. The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients.
    Yaldizli Ö, Penner IK, Frontzek K, Naegelin Y, Amann M, Papadopoulou A, Sprenger T, Kuhle J, Calabrese P, Radü EW, Kappos L, Gass A.
    Mult Scler; 2014 Mar; 20(3):356-64. PubMed ID: 23959709
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of corpus callosum damage on ipsilateral motor activation in patients with multiple sclerosis: a functional and anatomical study.
    Lenzi D, Conte A, Mainero C, Frasca V, Fubelli F, Totaro P, Caramia F, Inghilleri M, Pozzilli C, Pantano P.
    Hum Brain Mapp; 2007 Jul; 28(7):636-44. PubMed ID: 17080438
    [Abstract] [Full Text] [Related]

  • 20. Cortical and white matter lesion topology influences focal corpus callosum atrophy in multiple sclerosis.
    Platten M, Ouellette R, Herranz E, Barletta V, Treaba CA, Mainero C, Granberg T.
    J Neuroimaging; 2022 May; 32(3):471-479. PubMed ID: 35165979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.